EMD Millipore Launches Mobius CellReady

This new single-use bioreactor allows biopharmaceutical manufacturers to implement robust, single-use technologies that bring their drugs to market faster, with less risk. This single-use bioreactor further demonstrates EMD Millipore's commitment to support the industry's focus on implementing complete single-use bioprocess platforms.

The Mobius CellReady 50 L bioreactor is an important addition to the Mobius family. We've integrated a number of innovative features that deliver ease of use, reliability and operational flexibility compared to existing single-use systems, said Paul Chapman, Vice President of Biopharm Process Solutions. With this introduction, biopharmaceutical manufacturers now have a wider range of scalable single-use bioreactors offered by EMD Millipore, from three liters to two hundred liters, to support their needs from process development to clinical scale.

The Mobius CellReady 50 L bioreactor extends the company portfolio of single-use processing systems from cell culture through ultrafiltration/diafiltration. The innovative Mobius SensorReady technology offers the ultimate flexibility to configure process monitoring at the point of use, reducing the need to customize bioreactor process containers and enabling easy integration of new sensor technologies. The unique rigid base and top panel design of the bioreactor process container enables simple, reliable and robust installation improving operator confidence in set up and system operation. The Mobius CellReady Bioreactor system is available as a turn-key system complete with Finesse automation or as a modular system that can be integrated with customer's platform of choice.